Weight Loss and Blood Pressure Control (Pro)

Page created by George Marquez
 
CONTINUE READING
CONTROVERSIES IN
            HYPERTENSION
Weight Loss and Blood Pressure Control (Pro)
David W. Harsha, George A. Bray

O    verweight is an increasingly prevalent condition
     throughout the world. Current estimates, which are
probably conservative, indicate that at least 500 000 000
                                                                           25) of 2.42 for younger adults and 1.54 for older ones. The
                                                                           Nurses Health Study17 compared women with BMIs of less
                                                                           than 22 with those above 29 and found a 2- to 6-fold greater
people worldwide are overweight as defined by a body mass                  prevalence of hypertension among the obese.
index (BMI) of between 25.0 and 29.9 and an additional                        More recent data from the Framingham Study further
250 000 000 are obese with a BMI of 30.0 or higher.1 In the                support this relationship. Divided into BMI quintiles, Fra-
United States, recent data indicate that as much as 66% of the             mingham participants of both sexes demonstrated increasing
adult population is overweight or obese.2                                  blood pressures with increased overweight. In this instance
   Overweight and obesity are established risk factors for                 those in the highest BMI quintile exhibited 16 mm Hg higher
cardiovascular disease (CVD), stroke, noninsulin dependent                 systolic and 9 mm Hg higher diastolic blood pressures than
diabetes (NIDDM), certain cancers, and numerous other                      those in the lowest quintile. For systolic blood pressure this
disorders.3,4,5,6,7 It is also a risk factor for hypertension.8            translated into an increase of 4 mm Hg for each 4.5 kg of
   Hypertension, defined as a systolic blood pressure in                   increased weight.18 In younger Canadian adults, Rabkin et
excess of 140 mm Hg or a diastolic blood pressure higher                   al19 noted a 5-fold greater incidence of hypertension in
than 90 mm Hg, is also a globally increasing public health                 individuals with BMIs of more than 30 relative to those less
concern. Roughly 1 billion individuals worldwide are esti-                 than 20 for both sexes.
mated to exhibit clinically significant elevated blood pressure               The public health burden of hypertension is certainly
with about 50 million of those residing in the United States.8             enormous. Although perhaps impossible to tease out because
Hypertension, in turn, is associated with increased risk for               of associations with other risk factors, including overweight,
CVD, stroke, renal disease, and all-cause mortality.9,10,11,12             hypertension is clearly a major contributor to most categories
   The JNC VII report defines Stage 1 hypertension as blood                of chronic disease.20 Diseases of the heart and cerebrovascu-
pressure levels between 140 and 159 mm Hg systolic and 90                  lar diseases are the 1st and 3rd major causes of mortality in
and 99 diastolic. Additionally, the report establishes a cate-             the United States accounting for more than 1/3 of all deaths
gory of Prehypertension (Systolic blood pressure between                   annually.21 Hypertension is one of the clearest risk factors for
120 and 140 mm Hg or diastolic between 80 and 89 mm Hg).                   both of these causes of death.8 Therefore, reduction in
These 2 blood pressure classifications are deemed to be                    hypertension constitutes a major health goal for the immedi-
appropriate primary targets for lifestyle modification inter-              ate future. The federal government through the Healthy
ventions, including weight loss. Higher levels of blood                    People 2010 initiative proposes to increase to 50% those in
pressure, or stage 1 hypertension that is maintained over a                the adult hypertensive population with controlled hyperten-
long period, should be addressed primarily with medications                sion.22 This contrasts with the currently estimated figure of
or other physician directed treatments.                                    34%.8
   There is a positive relationship between overweight or                     Blood pressure control, the return of blood pressure to
obesity and blood pressure and risk for hypertension. As early             normotensive status, would have significant impact on mor-
as the 1920s, a significant association between body weight                tality from heart and cerebrovascular diseases. In clinical
and blood pressure was noted in men.13,14 In the intervening               trials antihypertensive therapy can result in reductions of
years, epidemiological studies have routinely confirmed this               incidence of stroke, myocardial infarction, and heart failure
association. The Framingham Study found that hypertension                  of between 20% and 50%.23 Ogden et al2 estimate that a
is about twice as prevalent in the obese as the nonobese of                12-mm Hg decline in systolic blood pressure maintained over
both sexes.15 Stamler and colleagues16 noted an odds ratio for             a period of 10 years in a population with initial stage 1
hypertension of obese relative to nonobese (BMI of less than               hypertension will reduce incident mortality by between 9%

  The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
  From the Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge.
  Correspondence to David W. Harsha, Pennington Biomedical Research Center, Louisiana State University System, 6400 Perkins Road, Baton Rouge,
LA 70808. E-mail david.harsha@pbrc.edu
  (Hypertension. 2008;51:1420-1425).
  © 2008 American Heart Association, Inc.
  Hypertension is available at http://hyper.ahajournals.org                                 DOI: 10.1161/HYPERTENSIONAHA.107.094011

                                                                    1420
Harsha and Bray          Weight Loss and Blood Pressure Control: Pro                  1421

and 11%. A population wide reduction of 5.5 mm Hg systolic          of the rennin-aldosterone-angiotensin system, increased acti-
or 3.0 mm Hg diastolic would result in an estimated 15%             vation of sympathetic nervous system, and changes in natri-
decline in incident coronary heart disease and a 27% decline        uretic peptide. The wide range of potential mechanisms also
in stroke.24,25                                                     may be a major factor in accounting for the apparent
   The challenge, therefore, is how to accomplish this goal.        heterogeneity in blood pressure response to any treatment.
Numerous treatments have proved efficacious, at least in the        Weight loss may variably and simultaneously impact one of
short term, in clinically significantly reducing blood pressure     more of these proposed routes of action. Because weight
levels.8 Of these, weight loss offers a number of attractive        status itself is a result of multiple causes, the fashion in which
features. We will consider the evidence for weight loss             it induces blood pressure change would not surprisingly be
mediated reductions in blood pressure accomplished through          variable.
the more traditional means of caloric restriction and other            Examination of these possible mechanisms raises one
lifestyle modification strategies. We will not review the data      important caveat about recommending weight loss for blood
associated with weight loss resulting from pharmacological          pressure control. This is the possibility that the effects of
or surgical interventions except as it may relate to mainte-        weight loss are mediated through some other system and that
nance of weight loss.                                               weight loss might not be an independent influence on blood
   Blood pressure alteration is theorized to be positively          pressure status.
associated with weight change. Although a number of studies            Because most weight loss is accomplished through dietary
have examined this from a perspective of weight loss and            manipulation, it is possible that some aspects of diet, when
reduction in blood pressure, there are little data in humans to     altered, are the true determinants of blood pressure reduction.
inform directly the idea that increase in weight relates to            Chief among perceived dietary influences on blood pres-
increased blood pressure at the individual level. Animal            sure is sodium consumption. A large literature supports the
studies have been the principle source of this information.         notion that decreasing sodium consumption below that typi-
Rocchini et al26 noted significant increases in blood pressure      cal in Western society will result in a decline of blood
accompanying weight gain from overfeeding in dogs. Hall et          pressure. Numerous epidemiological studies have demon-
al27 have confirmed this relationship.                              strated this relationship.34,35,36 Reductions in sodium intake
   On the other hand, numerous clinical interventions in            on the order of 75 mmol/d or less have been associated with
humans have examined the relationship of weight loss to             a decline in blood pressure of about 1.9 mm Hg systolic and
blood pressure change. Haynes28 reviewed 6 clinical trials          1.1 diastolic.36 The previously mentioned Trial of Hyperten-
available to that time relating weight loss and blood pressure,     sion Prevention found that a decrease of 44 mmol/d of
noting that 3 of them showed a significant impact of weight         sodium led to a 38% reduction in the incidence of hyperten-
loss whereas the other 3 did not demonstrate a clear impact.        sion in one of its treatment arms.30 The previously cited group
More recently, a meta-analysis of 25 studies on this topic was      analysis by Ebrahim and Smith32 found a pooled reduction of
performed by Neter et al.29 The authors concluded that a 1-kg       2.9 and 2.1 mm Hg blood pressure level with varying degrees
loss of body weight was associated with an approximate              of sodium restriction. The Dietary Alterations to Stop Hyper-
1-mm Hg drop in blood pressure. Further this blood pressure         tension Study (DASH-Na) found a maximum reduction of
reduction was accomplished without the necessity of also            about 6.7 mm Hg systolic and 3.5 diastolic in blood pressure
attaining normal weight status. The Trial of Hypertension           with an approximate 100-mmol/d reduction in sodium intake
Prevention (TOHP), one of the largest of these studies,             in those with elevated blood pressure on a typical American
included a weight loss intervention arm.30 In this instance, a      diet. An approximate 50 mmol/d reduction in sodium con-
2-kg loss in weight over a 6-month period resulted in a             sumption led to a blood pressure decline of 2.1 and
decline of 3.7 mm Hg in systolic and 2.7 mm Hg in diastolic         1.1 mm Hg systolic and diastolic.37 These findings were
blood pressure. In addition, a 42% decline in the instance of       produced in the absence of weight loss.
hypertension was noted on this sample.31                               The jury of scientific opinion is still out on the degree to
   Another analysis of multiple clinical trials of blood pres-      which weight loss or sodium restriction make independent
sure reduction was conducted by Ebrahim and Smith.32 In this        contributions to blood pressure reduction. An early study,
report, 8 trials were examined for the effects of weight loss on    Dahl et al38 found sodium restriction in low calorie diets to be
blood pressure and concluded that weight gain was associated        the primary cause of blood pressure reduction. This is also the
with increased blood pressure whereas weight loss resulted in       finding of Fagerberg et al.39 Several more recent studies have
reduced blood pressure. Blood pressure reductions were on           sided with weight loss as having an independent effect on
the order of 5.2 mm Hg both systolic and diastolic for varying      blood pressure reduction. Reisen et al40 found blood pressure
degrees of weight reduction.                                        reductions on the order of 3 mm Hg for each kg of weight loss
   Given the established association between weight change          in a sample of hypertensive men with no sodium restriction.
and blood pressure status, the question arises as to how this       Tuck et al41 and Maxwell et al42 additionally reported sodium
interaction functions physiologically. Rocchini33 identifies        independent effects of weight loss in a sample of hyperten-
numerous potential biological mechanisms by which weight            sive men as well.
loss or fat loss might lead to parallel declines in blood              Other dietary constituents have been implicated in the
pressure. Among them are reductions in insulin resistance,          control of blood pressure as well. Vegetarian diets are widely
enhanced sodium retention, alterations in vascular structure        associated with lower blood pressure levels.43 The Dietary
and function, changes in ion transport, enhanced stimulation        Approaches to Stop Hypertension Trial25 demonstrated that a
1422      Hypertension         June 2008

diet high in fruit, vegetable, and low-fat dairy servings could    interventions saw sustained weight loss and blood pressure
reduce blood pressure by 5.3 and 3.0 mm Hg systolic and            reduction. The active intervention without the DASH diet
diastolic blood pressure, respectively, in the absence of either   resulted in an average weight loss of 3.8 kg, that with the
weight loss or sodium restriction. Raben et al44 found that        DASH diet of 4.3 kg. Mean blood pressure reductions
significantly increased sucrose consumption led to notewor-        (systolic/diastolic) were 8.6/6.0 and 9.5/6.2 mm Hg for the
thy increases in both weight and fat mass as well as increases     same intervention arms, respectively. Urinary sodium reduc-
in blood pressure on the order of 4 mm Hg.                         tions were 18.4 and 24.5 mmol/d, respectively, for each group
   Likewise, physical activity has been shown to influence         as well.
blood pressure levels and is additionally a part of the               The Trial of Hypertension Prevention examined 181 par-
recommended regimen of weight loss strategies.8 Bouchard et        ticipants for weight loss or sodium reduction and blood
al45 examined the pertinent studies to that time and concluded     pressure for 7 years of follow-up.49 The sample was randomly
that approximately 1 hour per day of low to moderate level         assigned to a nontreated control, a sodium reduction, or a
physical activity could support weight loss but that such a        weight loss arm. The active component of the intervention
program would require several years to be completely effec-        lasted 18 months but individuals were further monitored for
tive. Ebrahim and Smith32 studied 8 clinical trials in which       blood pressure, weight, and dietary status for 7 years. Incident
exercise was a primary component in blood pressure reduc-          hypertension was the outcome variable of interest. The
tion. They found modest impacts on blood pressure reduction        weight loss group in the absence of sodium restriction, which
of 0.8 to 3.7 and 0.2 to 1.0 mm Hg resulting from primarily        had an average reduction of 5 kg in weight at 18 months,30
low levels of physical activity. A meta-analysis of the effects    demonstrated an incidence of hypertension of 18.9% after 7
of physical activity on blood pressure conducted by Kelley et      years. This contrasts with the sodium reduction in the absence
al46 led the authors to predict a decline in systolic blood        of weight loss group which found an incidence of hyperten-
pressure of 3 to 5 mm Hg associated with moderate physical         sion of 22.4% over the same period. These results were found
activity. Whelton et al47 reported a meta-analysis of normo-       in spite of the fact that much of the weight in the weight loss
tensives with significant reductions in blood pressure atten-      group had been regained at year 7.
dant to a variety of types of physical activity. Interestingly,       The Hypertension Prevention Trial followed 841 individ-
although there appears to be consensus among these investi-        uals for up to 3 years in caloric restriction/weight loss,
gators that increased physical activity drives somewhat larger     sodium reduction, caloric restriction and sodium reduction,
declines in blood pressure, the nature of this relationship is     and sodium reduction and increased potassium intervention
unclear. Although there might be a dose response relationship      arms.50 At 3 years of follow-up, the caloric restriction group
in the largest sense, most of these studies examine the impact     had maintained weight loss about 4% of baseline and dem-
of low to moderate physical activity and therefore have a cap      onstrated a 5.1/2.4-mm Hg reduction in blood pressure. The
on the degree they are capable of examining the full impact of     other dietary interventions resulted in smaller amounts of
exercise on blood pressure.                                        blood pressure reduction. The authors recommend caloric
   Because weight loss cannot be accomplished in the ab-           restriction and accompanying weight loss as the strategy of
sence of some combination of dietary or physical activity          choice in influencing blood pressure.
behaviors, separating independent effects of each component           Most recently the Weight Loss Maintenance program has
on blood pressure is extremely challenging. It is clear,           released its findings.51 In this instance, 1083 participants who
however, that weight loss, regardless of how obtained, is          had previously lost 8.5 kg or more were enrolled in a
associated with clinically significant reductions in blood         self-directed control or 1 of 2 treatment arms for study of
pressure.                                                          weight status over a 30-month period. Although all 3 groups
   Another issue is the extent to which maintained weight loss     exhibited some regain over this time, all maintained at least
continues to influence blood pressure status. The majority of      about 3 kg of weight loss. One arm, a monthly personal
studies linking weight loss to blood pressure reduction do so      contact group, maintained a larger 4.5-kg weight loss. All
only in the short term, usually examining impacts on a scale       levels of maintained weight loss would result in significant
of less than 1 year. The effect of longer term weight loss has     reductions in blood pressure in the general population.
predictably been much less examined. A number of clinical             Several other smaller scale studies have documented a
trials have examined the issue on the scale of more than 1         positive association between weight loss maintained for
year.                                                              periods of up to 2 years and reduced blood pressure.52,53,54 In
   The Premier Trial followed 810 individuals with initial         sum, it is clear that weight loss reduces blood pressure
elevated blood pressure or stage 1 hypertension for 18 months      reduction and that the blood pressure benefits are retained
after randomization to control or either of 2 putatively heart     over at least the short to midperiod, particularly in those who
healthy active interventions.48 Both active interventions          maintain the weight loss.31
counseled an increase in physical activity, and either a              The effects over longer time frames are less clear. Sjostrom
reduced fat and calorie diet, or a diet high in fruits, vegeta-    et al55 report 8 years of follow-up on the relationship of
bles, and low fat dairy servings using the DASH dietary            weight loss to blood pressure in a group 1157 obese partici-
model.25 Both active interventions also counseled reduction        pants who received gastric bypass surgery to induce weight
in sodium intake. Weight and blood pressure change were            loss. Initial weight losses of 18% of presurgical body weight
observed at baseline, at interim periods, and at the end of 18     were associated with a decline in blood pressure of about
months of intervention. At the end of the trial both active        12 mm Hg systolic and 8 mm Hg diastolic. Over a 6- to
Harsha and Bray           Weight Loss and Blood Pressure Control: Pro                  1423

8-year period, weights increased only very slightly in this             creases in blood pressure level. The result is a situation in
group whereas blood pressure levels rebounded and, at the               which it is not practicable to sort out independent causal
end of the study, were similar to or higher than untreated              effects. The argument then might emerge as to whether
controls. The authors themselves, however, are skeptical that           dietary or physical activity is a more desirable target for blood
this is a generalizeable finding pointing to methodological             pressure control. In these cases, however, data on recidivism
and analytic inconsistencies in their sample.56 It remains for          are not much more encouraging.62 Adoption of the entire
other research examining maintained weight loss.                        package of lifestyle changes, appropriate eating, physical
   Taken in its totality, it is clear that weight loss is associated    activity, and attention to weight management, yields the
with a decline in blood pressure at least in the short and              greatest likelihood of success.48,61 Overweight and obesity are
midterm. These findings extend even to those initially in the           best seen in this light as an ongoing major risk factor for
normotensive range and hold for both genders and all ethnic             hypertension, requiring life-long surveillance for both and
groups examined. This conclusion is endorsed by the JNC VII             immediate treatment as indicated by physician review.
expert panel and has become a part of the suggested lifestyle              And, at least in the case for blood pressure management,
armamentarium in combating hypertension.8 Undoubtedly,                  the bar may not be so high as for overall success in weight
much of the attractiveness of suggesting weight loss stems              loss. Data clearly show that modest reductions in weight can
from its multipurpose healthy nature. Not only is weight                have an impact on blood pressure.20,29,63 Weight loss in the
reduction associated with improved blood pressure control               range of 2 to 4 kg are associated with systolic blood pressure
but it confers benefits in the management of many other                 declines in the range of 3 to 8 mm Hg, a clinically significant
disorders including Type II diabetes, musculo-skeletal disor-           impact.30,31,32,48,49 Additionally, these impacts are felt rapidly
ders, some cancers, and other health concerns including all             as weight is lost usually within a few weeks48 and appear to
cause mortality.3,4,5,6,7                                               me maintained, with corresponding maintenance of weight
   Nevertheless, using weight loss as sole means of accom-              loss, for periods of at least 18 months to 3 years.49 Data on
plishing blood pressure control is not without problems. Chief          long term maintenance of weight loss are still to be produced.
among these is the difficulty involved with achieving and               Such studies are, clearly, both expensive and, by definition,
maintaining optimal weight. Most who attempt weight loss                time consuming. Emerging information from such programs
achieve little in this regard, and most who are initially               as the Weight Loss Maintenance study,51 however, yield
successful rebound to their early status or higher.57,58,59 In the      some confidence that, through appropriate treatment includ-
grimmest scenarios, the net result is not only a population at          ing lifestyle modification, weight can be lost and kept off.
increased biomedical risk but also suffering from a number of              Perhaps the largest problem with weight reduction as the
psycho-social insults resulting from these failures.60 Never-           primary mechanism for blood pressure control is that it is
theless, weight loss is successfully accomplished and is                ethically appropriate only for those with stage 1 hypertension
maintained by a significant percentage of those who attempt             or less. Clinical considerations require drug or other more
using only lifestyle modifications.61 The methods and strate-           intensive interventions in those with more elevated blood
gies used are still developing and, if careful attention is paid        pressures. Nevertheless, those in the prehypertensive and
to refining them, the result will undoubtedly be improvement            stage 1 hypertensive range constitute about 95 to 100 million
in those achieving weight loss and a decline in recidivism.62           Americans, about 40% of the adult population.64 This demo-
Maintenance of weight loss remains the challenge. Wing and              graphic is a very large target for weight loss intervention, and
Phelan61 report that approximately 20% of those attempting              one that has the potential for considerable public health
weight reduction via lifestyle modification are successful at           impact.
long term weight control. Research into the mechanisms by                  In conclusion, weight loss is clearly associated with a
which these results are obtained should increase these success          decrease in blood pressure as well as numerous other im-
rates. It should be noted that the impact of weight loss on             provements in biomedical status. Its accomplishment is done
blood pressure does not require achievement of optimal                  successfully as the major component of a spectrum of
weight (BMI ⬍25.0). Smaller decrements of weight loss                   appropriate lifestyle modifications. Strategies for achieving
clearly are of clinical significance in controlling blood pres-         long-term weight loss are emerging, and the proportion of
sure levels. Likewise, complete maintenance of weight loss is           those who are successful is growing. As a major public health
not necessary in this regard. Some recidivism in weigh loss is          issue, the management of overweight is of the highest priority
normal but, as long as weight is still below baseline level,            and is receiving major support from the federal government
there can be impact on blood pressure.31                                and other institutions. Successfully accomplishing national
   An additional issue, alluded to earlier, is the degree to            goals for weight management can supply additional benefits
which weight loss may be identified as an independent                   in the reduction of blood pressure and the associated biomed-
influence on blood pressure status. As noted weight loss, at            ical burden of risk for CVD and stroke.
least via traditional approaches, can only be accomplished
through some combination of diet and physical activity                                     Sources of Funding
changes. Numerous dietary components have been identified               Supported by Lower Mississippi Delta Nutrition and Health Initia-
as potentially impacting blood pressure, most notably sodium            tive (USDA Grant No. 58-0101-5-018, Amendment 1).
intake. But increased fruit and vegetable consumption is
clearly pertinent as are numerous other macro and micronu-                                       Disclosures
trients.25 Physical activity, likewise, is associated with de-          None.
1424         Hypertension              June 2008

                               References                                           25. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM,
 1. Seidell JC. Obesity, insulin resistance, and diabetes–a worldwide                   Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P-H, Karanja N. The
    epidemic. Br J Nutr. 2000;83:S5–S8.                                                 DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–1124.
 2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal                  26. Rocchini AP, Moorehead CP, DeRemer S, Bondie D. Pathogenesis of
    KM. Prevalence of overweight and obesity in the United States.                      weight-related changes in blood pressure in dogs. Hypertension. 1989;
    1999 –2004. JAMA. 2006;295:1549 –1555.                                              13:922–928.
 3. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson                27. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hyper-
    RR, Speizer FE, Hennekens CH. A prospective study of obesity and                    tension. Renal function and systemic hemodynamics. Hypertension.
    risk of coronary heart disease in women. N Engl J Med. 1990;322:                    1993;22:292–299.
    882– 889.                                                                       28. Haynes R. Is weight loss an effective treatment for hypertension? Can
 4. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE,               J Physiol Pharmacol. 1985;64:825– 830.
    Hennekens CH, Rosner B, Speizer FE, Willett WC. Dual effects of weight          29. Neter JE, Stam BE, Kok FJ, Grobbee DE, Gelseijnse JM. Influence of
    and weight gain on breast cancer risk. JAMA. 1997;278:1407–1411.                    weight reduction on blood pressure: a meta-analysis of randomized con-
 5. Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial                  trolled trials. Hypertension. 2003;42:878 – 884.
    cancer. Am J Epidemiol. 1998;148:234 –240.                                      30. TOHP-1. The effects of nonpharmacologic interventions on blood
 6. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky                  pressure of persons with high normal levels. Results of the Trials of
    RA, Speizer FE. Weight as a risk factor for clinical diabetes in women.             Hypertension Prevention, phase 1. JAMA. 1992;267:1213–1220.
    Am J Epidemiol. 1990;132:501–513.                                               31. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D,
 7. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm                   Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Rac-
    E, Colditz A. Impact of overweight on the risk of developing common                 zynski J, Brewer A, Singh B, Cohen J. Trials of Hypertension Prevention,
    chronic diseases during a 10-year period. Arch Intern Med. 2001;161:                phase II. Ann Intern Med. 2001;134:1–11.
    1581–1586.                                                                      32. Ebrahim S, Smith GD. Lowering blood pressure: a systematic review of
 8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL,                   sustained effects of non-pharmacological interventions. J Pub Hlth Med.
    Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, and the National           1998;20:441– 448.
    High Blood Pressure Education Program Coordinating Committee. Seventh           33. Rocchini AP. Obesity and Blood Pressure Regulation. Handbook of
    report of the Joint National Committee on Prevention, Detection, Evaluation,        Obesity: Etiology and Pathophysiology. Bray G and Bouchard C (eds),
    and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.              New York: Marcel Dekker, II ed, 2004 pp 873– 889.
 9. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot R,           34. INTERSALT Cooperative Research Group. INTERSALT: an interna-
    Goodwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart            tional study of electrolyte excretion and blood pressure. Results for
    disease. Part 1, prolonged differences in blood pressure: prospective               24-hour urinary sodium and potassium excretion. BMJ. 1988;297:
    observational studies corrected for regression dilution bias. Lancet. 1990;         319 –328.
    335:765–774.                                                                    35. Elliot P, Stamler J, Nichols R, Dyer A, Stamler R, Kesteloot H, Marmot
10. Kannel WB, Wilson PW, Zhang TJ. The epidemiology of impaired                        M. INTERSALT revisited: further analyses of 24-hour sodium excretion
    glucose tolerance and hypertension. Am Heart J. 1991;12:1268 –1273.                 and blood pressure variation within and across populations. BMJ. 1996;
11. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:                         312:1249 –1254.
    101–106.                                                                        36. Cutler JA, Follman D, Allender PS. Randomized trials of sodium
12. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE,                   reduction: an overview. Am J Clin Nutr. 1997;65:643S– 651S.
    Shulman NB, Stamler J. Blood pressure and end-stage renal disease in            37. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D,
    men. N Engl J Med. 1996;334:13–18.                                                  Obarzanek E, Conlin PR, Miller ER, Simmons-Morton DG, Karanja N,
13. Symonds B. Blood pressure of healthy men and women. JAMA. 1923;8:                   Pao-Hwa L for the DASH-Sodium Collaborative Research Group. Effects
    232–236.                                                                            on Blood Pressure of Reduced Dietary Sodium and the Dietary
14. Dublin LI. Report of the Joint Committee on Mortality of the Association            Approaches to Stop Hypertension (DASH) Diet. N Engl J Med. 2001;
    of Life Insurance Medical Directors. New York: Actuarial Society of                 344:3–10.
    America, 1925.                                                                  38. Dahl LK, Silver L, Christie RW. The role of salt in the fall of blood
15. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an                      pressure accompanying reduction in obesity. N Engl J Med. 1958;258:
    independent risk factor for cardiovascular disease: a 26-year follow-up of          1186 –1192.
    participants in the Framingham Heart Study. Circulation. 1983;67:               39. Fagerberg B, Andersson OK, Isaksson B, Björntorp P. Blood pressure
    968 –977.                                                                           control during weight reduction in obese hypertensive men: separate
16. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts R. Weight and                effects of sodium and energy restriction. BMJ. 1984;288:11–14.
    blood pressure: findings in hypertension screening of 1 million                 40. Reisen E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B.
    Americans. JAMA. 1978;240:1607–1609.                                                N Engl J Med. 1978;298:1– 6.
17. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Susan E.             41. Tuck MI, Sowers J, Dornfield L, Kledzik G, Maxwell M. The effect of
    Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality                   weight reduction on blood pressure plasma renin activity and plasma
    among women. N Engl J Med. 1995;333:677– 685.                                       aldosterone level in obese patients. N Engl J Med. 1981;304:930 –933.
18. Higgins M, Kamel W, Garrison R, Pinsky J, Stokes J. Harzards of                 42. Maxwell MH, Kushiro T, Dornfeld LP, Tuck ML, Waks AU. BP changes
    obesity-the Framingham experience. Acta Med Scand. 1998;723:                        in obese hypertensive subjects during rapid weight loss. Comparison of
    23–26.                                                                              restricted v unchanged salt intake. Arch Intern Med. 1984;144:
19. Rabkin SW, Chen Y, Leiter L, Liu L, Reeder BA. Canadian Heart Health                1581–1584.
    Surveys Research Group. Risk factor correlates of body mass index.              43. Sacks FM, Rosner B, Kass EH. Blood pressure in vegetarians. Am J
    CMAJ. 1997;157:S26 –S31.                                                            Epidemiol. 1974;100:390 –398.
20. Havas S, Roccella EJ, Lenfant C. Reducing the Public Health Burden              44. Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with
    From Elevated Blood Pressure Levels in the United States by Lowering                artificial sweeteners: different effects on ad libitum food intake and body
    Intake of Dietary Sodium. Am J Public Health. 2004;94:19 –22.                       weight after 10 wk of supplementation in overweight subjects. Am J Clin
21. Heron MP, Smith BL. Deaths: Leading Causes for 2003. National Vital                 Nutr. 2002;721–729.
    Statistics Reports. Hyattsville, MD: National Center for Health Statistics.     45. Bouchard C, Deprés J-P, Tremblay A. Exercise and obesity. Obes Res.
    Natl Vital Stat Rep. 2007;55:1–95.                                                  1983;1:133–147.
22. US Dept Health Human Services Healthy People 2010. Vol. 1. Wash-                46. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood
    ington, DC, 2000.                                                                   pressure: A meta-analysis of randomized, controlled trials. Hypertension.
23. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium                   2000;35:838 – 843.
    antagonists, and other blood-pressure-lowering drugs: results of prospec-       47. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood
    tively designed overviews of randomised trials. Blood Pressure Lowering             pressure: A meta-analysis of randomized, controlled trials. Ann Intern
    Treatment Trialists’ Collaboration. Lancet. 2000;356:1955–1964.                     Med. 2002;136:493–503.
24. Cutler JA, Psaty BM, MacMahon S, Furberg CD. Public health issues in            48. Elmer PJ, Obarzanek E, Vollmer WM, Morton-Simons D, Stevens VJ,
    hypertension control: what has been learned from clinical trials. In: Laragh,       Young DR, Lin P-H, Champagne C, Harsha DW, Svetkey LP, Ard J,
    JH and Brenner, Bm (eds) Hypertension: Pathophysiology, Diagnosis, and              Brantley PJ, Proschan MA, Erlinger TP, Appel LJ for the PREMIER
    Management. II ed. Vol 1. New York: Raven Pr, 1995: 253–270.                        Collaborative Research Group. Effects of comprehensive lifestyle modi-
Harsha and Bray                Weight Loss and Blood Pressure Control: Pro                              1425

      fication on diet, weight, physical fitness, and blood pressure control:         55. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L. Differential
      18-month results of a randomized trial. Ann Intern Med. 2006;144:                   long-term effects of intentional weight loss on diabetes and hyper-
      485– 495.                                                                           tension. Hypertension. 2000;36:20 –25.
49.   He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects            56. Sjöström CD, Peltonen M, Siöström L. Blood pressure and pulse pressure
      of weight loss and dietary sodium reduction on incidence of hypertension.           during long-term weight loss in the obese: the Swedish Obese Subjects
      Hypertension. 2000;35:544 –549.                                                     (SOS) Intervention Study. Obes Res. 2001;9:188 –195.
50.   Hypertension Prevention Trial Research Group. The hypertension pre-             57. National Institutes of Health Technology Assessment Conference Panel.
      vention trial: three-year effects of dietary changes on blood pressure. Arch        Methods for voluntary weight loss and control. Ann Intern Med. 1993;
      Intern Med. 1990;150:153–162.                                                       119:764 –770.
51.   Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM,             58. Institute of Medicine. Weighing the options: criteria for evaluating weight
      Vollmer WM, Gullion CM, Funk K, Smith P, Samuel-Hodges C, Myers                     management programs. 1995; Washington, DC. Govt. Pr Off.
      V, Lien LF, Laferriere D, Kennedy B, Jerome GJ, Heinith F, Harsha DW,           59. Jeffery RW, Drewnowski A, Epstein luteinizing hormone (LH), Stunkard
      Evans P, Erlinger TP, Dalcin AR, Coughlin J, Charleston J, Champagne                AJ, Wilson GT, Wing RR, Hill DR. Long-term maintenance of weight
      CM, Bauck A, Ard JD, Aicher K for the Weight Loss Maintenance                       loss: current status. Health Psychol. 2000;19:5–16.
      Collaborative Research Group. Comparison of strategies for sustaining           60. Kassirer J, Angell M. Losing weight–an ill-fated New Year’s resolution.
      weight loss, the weight loss maintenance randomized controlled trial.               NEJM. 1998;338:52–54.
      JAMA. 2008;299:1139 –1148.                                                      61. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr.
52.   Dornfield TP, Maxwell MH, Waks AU, Schroth P, Tuck MI. Obesity and                  2005;82:222S–225S.
      hypertension: long-term effects of weight reduction on blood pressure. Int      62. Bray GA. Nutrition, Diet, and Treatment of Overweight. Contemporary
      J Obes. 1985;9:381–389.                                                             Diagnosis and Management of Obesity and the Metabolic Syndrome.
53.   Reisen E, Frohlich ED. Effects of weight reduction on arterial pressure.            Newtown, PA: Handbooks in Health Care. III ed. 2003 Chpt 8: 202–239.
      J Chron Dis. 1982;33:887– 891.                                                  63. Cutler JA. Randomized clinical trials of weight reduction in nonhyper-
54.   Davis BR, Blaufox D, Oberman A, Wassertheil-Smoller S, Zimbaldi N,                  tensive persons. Ann Epidemiol. 1991;1:363–370.
      Cutler JA, Kirchner K, Langford HG. Reduction in long-term antihyper-           64. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of
      tensive medication requirements: effects of weight reduction by dietary             prehypertension and hypertension in United States: National Health and
      intervention in overweight persons with mild hypertension. Arch Intern              Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:
      Med. 1993;153:1773–1782.                                                            CR403–CR409.

                     Response to Weight Loss and Blood Pressure Control: The Pro Side
                                                                            Allyn L. Mark

      Harsha and Bray argue that diet and behavioral modification produce significant and sustained weight loss and that this
      modest diet-induced weight loss diet is effective in treating mild hypertension. I remain unconvinced and deeply skeptical
      on both points. I refer the reader to my companion article in this issue and to my recent article “Weight reduction for
      treatment of obesity-associated hypertension: nuances and challenges” in Current Hypertension Reports (2007;9:368 –372).
      Harsha and Bray highlight the recent Weight Loss Maintenance trial. I’m unimpressed. Like previous trials, it shows weight
      regain with only modest residual weight loss. The duration of the trial was not long enough to establish sustained weight
      loss, and there was no measurement of blood pressure. Further, there are questions about the pragmatism of long-term
      widespread lifestyle modification in the “real world.” In addition, although even modest weight loss produces an early
      reduction in blood pressure, the long-term reductions in blood pressure are much less impressive than the short term
      reductions. One more nail in the coffin of the idea that weight loss is the answer to hypertension in obesity is the following.
      In patients undergoing bariatric surgery for morbid obesity, although blood pressure decreases initially, it returns to control
      levels after 6 to 8 years despite substantial and sustained decreases in body weight. In summary, chronic blood pressure
      reduction during dieting and weight loss is not as sustained or pronounced as generally assumed.
You can also read